pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
Drugs
by stage
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
browse
Most catalysts
Recently active
All drugs →
Companies
Patent cliff
Calendar
what
Trial readouts
PDUFA dates
Approvals
Earnings
when
Upcoming
Month grid
Recently passed
◐
Sign In
Subscribe
home
jobs
news
search
the cabinet
Drugs
6,918
products tracked ·
6,918
matching
★ save view
↓
export CSV
search
phase
all
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
sort
catalysts
recent
name
therapeutic area
all
Oncology
1831
Infectious Disease
718
Cardiology
425
Pulmonology
396
Immunology
371
Ophthalmology
368
Dermatology
300
Women's Health
view
list
cards
Phase 2
TTX-333
Evitar
Scar
Temple Therapeutics BV
0
catalysts
Preclinical
TTX-siPD-L1
Pancreatic Ductal Adenocarcinoma
$RNAZ
Transcode Therapeutics, Inc.
0
catalysts
Phase 2
TTXMC-138
Solid Tumor
$RNAZ
Transcode Therapeutics, Inc.
0
catalysts
Phase 2
← prev
page 143 of 231
next →
131
Pain
89
Neurology
1
TUB-040
Non-Small Cell Lung Cancer
Tubulis GmbH
0
catalysts
Phase 1
TVGN-489
Coronavirus Disease 2019 (COVID-19)
$TVGN
Tevogen Bio Holdings Inc.
0
catalysts
Phase 2
TVI-Kidney-1
Renal Cell Carcinoma
TVAX Biomedical Inc
0
catalysts
Phase 2
TX-45
Pulmonary Hypertension
$TECX
Tectonic Therapeutic, Inc.
0
catalysts
Phase 1
TXA-709
Methicillin-Resistant Staphylococcus aureus (MRSA) Infections
TAXIS Pharmaceuticals Inc
0
catalysts
Preclinical
TY-0609
Breast Cancer
TYK Medicines Inc
0
catalysts
Preclinical
TYG-100
Gastrointestinal Tract Cancer
Tyg Oncology Ltd
0
catalysts
Phase 1
TYRA-200
Bile Duct Cancer (Cholangiocarcinoma)
$TYRA
Tyra Biosciences, Inc.
0
catalysts
Phase 1
TYRA-430
Metastatic Hepatocellular Carcinoma (HCC)
$TYRA
Tyra Biosciences, Inc.
0
catalysts
TYZAVAN
TYZAVAN (VANCOMYCIN)
HIKMA
0
catalysts
Preclinical
TZT-102
Multiple Myeloma (Kahler Disease)
Tezcat Biosciences Inc
0
catalysts
Phase 3
Tardoxal
Seizures
$MCUJF
MEDICURE INC
0
catalysts
Phase 2
Temferon
Glioblastoma Multiforme (GBM)
Genenta Science SpA
0
catalysts
Preclinical
TerXT
Schizophrenia
Terran Biosciences Inc
0
catalysts
Preclinical
TerXT LAI
Schizophrenia
Terran Biosciences Inc
0
catalysts
Marketed
Testim
Testosterone Par (testosterone)
Secondary (Hypogonadotropic) Hypogonadism
Par Pharmaceutical Inc
0
catalysts
Phase 3
Tevimbra
Tevimbra (tislelizumab-jsgr)
Small-Cell Lung Cancer
Programmed cell death protein 1
$ONC
BeOne Medicines Ltd.
0
catalysts
Preclinical
Therapeutic Inducers of NK cell Killing (ThINKK)
Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia)
Centre Hospitalier Universitaire Sainte-Justine
0
catalysts
Preclinical
ThermoStem
Obesity
$BRTX
BioRestorative Therapies, Inc.
0
catalysts
Phase 3
Thrombosomes
Hemostasis
Cellphire Inc
0
catalysts
Preclinical
Tissue Healing Accelerate (THA)
Wounds
$XAGE
Longevity Health Holdings, Inc.
0
catalysts
Phase 2
Tolasure
Epidermolysis Bullosa Simplex
Biomendics LLC
0
catalysts
Phase 3
Trappsol Cyclo
Niemann-Pick Disease Type C
Cyclo Therapeutics Inc
0
catalysts
Preclinical
Treatment of Sickle Cell Disease
Sickle Cell Disease
$PFE
PFIZER INC
0
catalysts
Phase 2
Tregcel
Kidney Transplant Rejection
Singulera Therapeutics Inc
0
catalysts
Marketed
Trelegy Ellipta
Trelegy Ellipta ((fluticasone furoate + umeclidinium bromide + vilanterol trifenatate))
Asthma
GlaxoSmithKline LLC
0
catalysts
Preclinical
TriFiloVax
Ebolavirus Infections (Ebola Hemorrhagic Fever)
$SNGX
SOLIGENIX, INC.
0
catalysts
